{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T03:14:23Z","timestamp":1794798863187,"version":"4.9.1"},"reference-count":44,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special Fund","doi-asserted-by":"publisher","award":["2022\u20101G\u20103011"],"award-info":[{"award-number":["2022\u20101G\u20103011"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special Fund","doi-asserted-by":"publisher","award":["2022\u20102\u20102185"],"award-info":[{"award-number":["2022\u20102\u20102185"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and Aim<\/jats:title><jats:p>With the global increase in chronic liver disease and cirrhosis, there is an increasing need to identify non\u2010invasive biomarkers to measure the severity of disease progression while reducing reliance on pathological biopsies. This study aimed to comprehensively evaluate the diagnostic value of PRO\u2010C3 as a biomarker for staging liver fibrosis in patients with viral hepatitis or fatty liver disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Articles published until January 6, 2023, were searched in the PubMed, Embase, MEDLINE, Web of Science, and Cochrane Library databases. The Quality Assessment of Diagnostic Accuracy Studies\u20102 tool was used to evaluate the quality of the included studies. Pooled sensitivity, specificity, diagnostic odds ratio, and likelihood ratios were integrated using a random\u2010effects model, and a summary receiver operating characteristic curve was constructed. Publication bias was also detected. Subgroup and meta\u2010regression analyses, as well as sensitivity analysis, were also performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fourteen studies with 4315 patients were included. Summary area under the curve of PRO\u2010C3 for the identification of significant fibrosis (\u2265\u00a0F2) and advanced fibrosis (\u2265\u00a0F3) was 0.80 (95% confidence interval: 0.76\u20130.83). Subgroup and meta\u2010regression analyses suggested that disease type and sample size may be the primary factors of heterogeneity in PRO\u2010C3 diagnosis of \u2265\u00a0F2, while study design, study sample type, and enzyme\u2010linked immunosorbent assay kit brand may be the primary sources of heterogeneity in PRO\u2010C3 diagnosis of \u2265\u00a0F3.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>PRO\u2010C3 demonstrated clinically meaningful diagnostic accuracy when used alone as a non\u2010invasive biomarker for diagnosing the liver fibrosis stage in individuals with viral hepatitis or fatty liver disease.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jgh.16240","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T06:29:08Z","timestamp":1686205748000},"page":"1018-1027","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of blood\u2010based PRO\u2010C3 testing as a diagnostic marker for staging liver fibrosis: A systematic review and meta\u2010analysis"],"prefix":"10.1111","volume":"38","author":[{"given":"Menglu","family":"Liu","sequence":"first","affiliation":[{"name":"State Clinical Drug Trial Institution Beijing You An Hospital, Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanying","family":"Qiu","sequence":"additional","affiliation":[{"name":"State Clinical Drug Trial Institution Beijing You An Hospital, Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Clinical Drug Trial Institution Beijing You An Hospital, Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Mei","sequence":"additional","affiliation":[{"name":"Interventional Therapy Center for Oncology Beijing You An Hospital, Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Tang","sequence":"additional","affiliation":[{"name":"The First Department of Liver Center Beijing You An Hospital, Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxue","family":"Gao","sequence":"additional","affiliation":[{"name":"Beijing Institute of Hepatology Beijing You An Hospital, Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiu","family":"Zhu","sequence":"additional","affiliation":[{"name":"State Clinical Drug Trial Institution Beijing You An Hospital, Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Huang","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases Beijing You An Hospital, Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9563-9194","authenticated-orcid":false,"given":"Haibin","family":"Yu","sequence":"additional","affiliation":[{"name":"State Clinical Drug Trial Institution Beijing You An Hospital, Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-021-01788-x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.07.060"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114764"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2018.09.002"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13597"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29721"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.11.048"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14669"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1997"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30383-8"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3720571"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2018.10"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29302"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.11.013"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30610"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14390"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04226-0"},{"key":"e_1_2_6_19_1","first-page":"1920","article-title":"Systematic review with meta\u2010analysis: diagnostic accuracy of Pro\u2010C3 for hepatic fibrosis in patients with non\u2010alcoholic fatty liver disease","volume":"9","author":"Mak AL","year":"2021","journal-title":"Biomedicine"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2017.1392596"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16513"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137302"},{"key":"e_1_2_6_23_1","first-page":"1032A","article-title":"Diagnostic accuracy of soluble SCD163 for the detection of severe fibrosis in patients with nonalcoholic fatty liver disease [Abstract]","volume":"70","author":"Rosso C","year":"2019","journal-title":"Hepatology"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154958"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8798"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-8-201110180-00009"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240201"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80226-6"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-017-5078-3"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-2-9"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.02.022"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12474"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1439"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.01.016"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.06.004"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-2578"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30163"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100317"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15427"},{"key":"e_1_2_6_43_1","unstructured":"KnochelJ KechagiasS BergenholmLet al.Pro\u2010C3 but not PC3X is increased with advanced fifibrosis stage in a longitudinal cohort of non\u2010alcoholic fatty liver disease (NAFLD) patients. Proceedings of the AASLD Virtual; 13\u201316 November2020."},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30457-y"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.016"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgh.16240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T11:55:55Z","timestamp":1744113355000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jgh.16240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1111\/jgh.16240"],"URL":"https:\/\/doi.org\/10.1111\/jgh.16240","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,7]]},"assertion":[{"value":"2022-08-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}